Viewing nowPitagone Tablet (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 200701043 · Notified 2007.01.09 · Insurance code 648504200
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with Type 2 diabetes. It is more effective when taken alongside dietary and exercise therapy. It can be used alone but may also be combined with sulfonylureas, metformin, or insulin if adequate effects are not obtained from other oral hypoglycemic agents. Additionally, for patients with Type 2 diabetes, nutritional counseling, weight loss, and regular exercise are vital for enhancing treatment efficacy. These approaches aid in maintaining the efficacy of drug therapy as well as in initial treatment. Therefore, this drug is effectively utilized to improve blood sugar control.
This medicine is administered orally once daily, regardless of meals. For monotherapy, treatment may be started at 15 mg once daily and increased to 30 mg once daily if the effect is insufficient. For combination therapy, administer 15 mg once daily with a sulfonylurea, metformin, or insulin. The maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.
This drug can cause or worsen cardiac dysfunction known as congestive heart failure in some patients. After initiating treatment or increasing the dose, it is crucial to monitor for symptoms of heart failure, such as sudden significant weight gain, shortness of breath, or swelling. If any symptoms of heart failure occur, immediate medical attention should be sought, and the drug may need to be discontinued or the dose reduced if necessary. Patients with heart failure or a history of heart failure should not use this drug. When used in conjunction with insulin, this drug may cause fluid retention and worsen heart failure, so patients with heart disease should exercise particular caution. If symptoms such as hematuria, urinary problems, or urgency arise during treatment, they may indicate bladder cancer, and immediate notification to a physician is necessary. This drug should not be used in patients with poor liver function, severe kidney disease, diabetic ketoacidosis, Type 1 diabetes, active bladder cancer, and others. There is a risk of hypoglycemia when used with other antidiabetic agents, so it is essential to be aware of hypoglycemia symptoms and management, and adjust the doses of other medications if necessary. This drug can cause weight gain and edema, so periodic monitoring of weight changes and edema symptoms is necessary. For premenopausal women, this drug may stimulate ovulation, increasing the risk of pregnancy, so using appropriate contraceptive methods is advised. Regular blood sugar and liver function tests during treatment are vital, and any symptoms of liver damage (fatigue, loss of appetite, jaundice, etc.) should be reported to a doctor immediately. Elderly patients, especially those over 75 years of age, should exercise increased caution when using this drug, as they may have a higher likelihood of adverse reactions. This drug may affect the fetus during pregnancy, so women who are pregnant or may become pregnant should avoid using it, and breastfeeding individuals should consult their doctor. In the event of overdose, specific antidotes are not available, so appropriate treatment should be administered based on symptoms. The safety and efficacy of this drug in children under 18 years of age have not been established, so administration is not recommended. This drug's blood concentration may vary when taken with other medications, so consult a physician when starting or stopping any other drugs.
Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, edema, abdominal distension, weight gain, hypoglycemia, urinary tract infection, lumbago, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, cardiovascular-related mortality, worsening congestive heart failure, emergency room visits due to congestive heart failure, edema, liver failure, diabetic macular edema accompanied by decreased vision, elevated serum ALT levels, decreased hemoglobin, decreased hematocrit, elevated serum creatine kinase, bladder cancer, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle rigidity, discomfort in the head, increased liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee abnormalities, weakness in the arms, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, fractures
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a container that prevents exposure to light and air, avoiding humid areas. The storage temperature should be maintained between 15 and 30 degrees Celsius, ideally around 25 degrees.
Round, convex tablet that is white to grayish-white in color.
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.